Prostate-specific membrane antigen (PSMA), a 100 kDa type II-transmembrane glycoprotein with folate hydrolase and neurocarboxypeptidase activity, is expressed in prostate epithelium and upregulated on the surface of prostatic adenocarcinoma cells [5, 6]. This evidence concerns the gene FOLH1 and prostate adenocarcinoma.